Notice Information
Notice Title
Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine
Notice Description
This Framework Agreement is for the supply of Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to Health Boards across NHS Scotland. The Framework Agreement was awarded in the eighteen (18) Lots listed in this notice
Lot Information
Lot 2 Oxycodone Injections
The Supply of Oxycodone Injections to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single supplier.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 1 Baclofen Intrathecal InjectionsSupply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single supplier.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 4 Oxycodone Hydrochloride Prolonged Release TabletsThe Supply of Oxycodone Hydrochloride Prolonged Release Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 5 Buprenorphine PatchesThe supply of Buprenorphine Patches to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire
Lot 6 Fentanyl Tablets (Sublingual)The Supply of Fentanyl Tablets (Sublingual) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire
Lot 7 Fentanyl Sf Tablet (Buccal)Supply of Fentanyl Sf Tablets(Buccal) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 8 - Fentanyl Transdermal PatchSupply of Fentanyl Transdermal Patch to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 9 - Hydromorphone CapsuleSupply of Hydromorphone Capsule to NHS Scotland in a range of presentations. The Authority intends awarding each product lines as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire
Lot 10 - Lidocaine Chlorhexidine GelSupply of Lidocaine Chlorhexidine Gel to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 11 - Morphine Sulfate Modified-Release capsule (12Hr)Supply of Morphine Sulfate Modified-Release capsule (12hr) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 12 - Morphine Sulfate Modified-Release capsule (24Hr)The Supply of Morphine Sulfate Modified-Release capsule (24Hr) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 13 - Morphine Sulfate Modified-Release TabletThe Supply of Morphine Sulfate Modified-Release Tablet to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 14 - Oxycodone Hydrochloride CapsuleThe Supply of Oxycodone Hydrochloride Capsule to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 15 - Propofol InjectionThe Supply of Propofol Injection to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 16 - Tramadol Hydrochloride Modified Release TabletThe Supply of Tramadol Hydrochloride Modified Release Tablet to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 17 - Oxycodone Oral SolutionThe Supply of Oxycodone Oral Solution to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 18 - All Other Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic MedicinesSupply of all other Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine in a range of presentations. The Authority intends awarding each line within this Lot to a single supplier.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 3 Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For InjectionThe Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single supplier.
Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000510037
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB310681
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- OJEU - F3 - Contract Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £30,788,325 £10M-£100M
- Lots Value
- £30,788,319 £10M-£100M
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 16 Feb 20188 years ago
- Submission Deadline
- 3 Oct 2017Expired
- Future Notice Date
- Not specified
- Award Date
- 22 Dec 20178 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")
- Contact Name
- Mairi Gibson
- Contact Email
- mairi.gibson@nhs.net
- Contact Phone
- +44 1698794544
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH12 9EB
- Post Town
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP294282
Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine - Supply of Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to Health Boards across NHS Scotland. -
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB310681
Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine - This Framework Agreement is for the supply of Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to Health Boards across NHS Scotland. The Framework Agreement was awarded in the eighteen (18) Lots listed in this notice
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-r6ebe6-0000510037-2018-02-16T00:00:00Z",
"date": "2018-02-16T00:00:00Z",
"ocid": "ocds-r6ebe6-0000510037",
"initiationType": "tender",
"parties": [
{
"id": "org-15",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"name": "Mairi Gibson",
"email": "mairi.gibson@nhs.net",
"telephone": "+44 1698794544",
"url": "http://www.publictendersscotland.publiccontractsscotland.gov.uk"
},
"roles": [
"buyer",
"centralPurchasingBody",
"reviewBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
},
{
"id": "org-29",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"name": "Mairi Gibson",
"email": "mairi.gibson@nhs.net",
"telephone": "+44 1698794544",
"url": "http://"
},
"roles": [
"buyer",
"centralPurchasingBody",
"reviewBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
}
}
],
"buyer": {
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
"id": "org-29"
},
"tender": {
"id": "NP40917",
"title": "Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine",
"description": "This Framework Agreement is for the supply of Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to Health Boards across NHS Scotland. The Framework Agreement was awarded in the eighteen (18) Lots listed in this notice",
"status": "complete",
"items": [
{
"id": "2",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014"
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "2"
},
{
"id": "1",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "1"
},
{
"id": "4",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "4"
},
{
"id": "5",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "5"
},
{
"id": "6",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014"
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "6"
},
{
"id": "7",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "7"
},
{
"id": "8",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "8"
},
{
"id": "9",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014"
},
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "9"
},
{
"id": "10",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "10"
},
{
"id": "11",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "11"
},
{
"id": "12",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "12"
},
{
"id": "13",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014"
},
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "13"
},
{
"id": "14",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014"
},
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "14"
},
{
"id": "15",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "15"
},
{
"id": "16",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "16"
},
{
"id": "17",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "17"
},
{
"id": "18",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "18"
},
{
"id": "3",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
},
{
"region": "UKM"
}
],
"relatedLot": "3"
}
],
"value": {
"amount": 30788325,
"currency": "GBP"
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"mainProcurementCategory": "goods",
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"tenderPeriod": {
"endDate": "2017-10-03T17:00:00Z"
},
"awardPeriod": {
"startDate": "2017-10-03T17:00:00Z"
},
"documents": [
{
"id": "SEP294282",
"documentType": "contractNotice",
"title": "Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine",
"description": "Supply of Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to Health Boards across NHS Scotland.",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP294282",
"format": "text/html"
},
{
"id": "FEB310681",
"documentType": "awardNotice",
"title": "Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine",
"description": "This Framework Agreement is for the supply of Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines to Health Boards across NHS Scotland. The Framework Agreement was awarded in the eighteen (18) Lots listed in this notice",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB310681",
"format": "text/html"
}
],
"lots": [
{
"id": "2",
"title": "Lot 2 Oxycodone Injections",
"description": "The Supply of Oxycodone Injections to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single supplier.",
"status": "complete",
"value": {
"amount": 945501,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed",
"electronicCataloguePolicy": "required"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "1",
"title": "Lot 1 Baclofen Intrathecal Injections",
"description": "Supply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single supplier.",
"status": "complete",
"value": {
"amount": 172488,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed",
"electronicCataloguePolicy": "required"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "4",
"title": "Lot 4 Oxycodone Hydrochloride Prolonged Release Tablets",
"description": "The Supply of Oxycodone Hydrochloride Prolonged Release Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.",
"status": "complete",
"value": {
"amount": 508268,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed",
"electronicCataloguePolicy": "required"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "5",
"title": "Lot 5 Buprenorphine Patches",
"description": "The supply of Buprenorphine Patches to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.",
"status": "complete",
"value": {
"amount": 316849,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed",
"electronicCataloguePolicy": "required"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire"
}
},
{
"id": "6",
"title": "Lot 6 Fentanyl Tablets (Sublingual)",
"description": "The Supply of Fentanyl Tablets (Sublingual) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.",
"status": "complete",
"value": {
"amount": 443104,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire"
}
},
{
"id": "7",
"title": "Lot 7 Fentanyl Sf Tablet (Buccal)",
"description": "Supply of Fentanyl Sf Tablets(Buccal) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.",
"status": "complete",
"value": {
"amount": 28171,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "8",
"title": "Lot 8 - Fentanyl Transdermal Patch",
"description": "Supply of Fentanyl Transdermal Patch to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.",
"status": "complete",
"value": {
"amount": 397032,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "9",
"title": "Lot 9 - Hydromorphone Capsule",
"description": "Supply of Hydromorphone Capsule to NHS Scotland in a range of presentations. The Authority intends awarding each product lines as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.",
"status": "complete",
"value": {
"amount": 76378,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire"
}
},
{
"id": "10",
"title": "Lot 10 - Lidocaine Chlorhexidine Gel",
"description": "Supply of Lidocaine Chlorhexidine Gel to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.",
"status": "complete",
"value": {
"amount": 1065982,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "11",
"title": "Lot 11 - Morphine Sulfate Modified-Release capsule (12Hr)",
"description": "Supply of Morphine Sulfate Modified-Release capsule (12hr) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.",
"status": "complete",
"value": {
"amount": 2152,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "12",
"title": "Lot 12 - Morphine Sulfate Modified-Release capsule (24Hr)",
"description": "The Supply of Morphine Sulfate Modified-Release capsule (24Hr) to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.",
"status": "complete",
"value": {
"amount": 1414,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "allowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "13",
"title": "Lot 13 - Morphine Sulfate Modified-Release Tablet",
"description": "The Supply of Morphine Sulfate Modified-Release Tablet to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.",
"status": "complete",
"value": {
"amount": 284570,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "14",
"title": "Lot 14 - Oxycodone Hydrochloride Capsule",
"description": "The Supply of Oxycodone Hydrochloride Capsule to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.",
"status": "complete",
"value": {
"amount": 475315,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "15",
"title": "Lot 15 - Propofol Injection",
"description": "The Supply of Propofol Injection to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.",
"status": "complete",
"value": {
"amount": 1751444,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "16",
"title": "Lot 16 - Tramadol Hydrochloride Modified Release Tablet",
"description": "The Supply of Tramadol Hydrochloride Modified Release Tablet to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.",
"status": "complete",
"value": {
"amount": 19139,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "17",
"title": "Lot 17 - Oxycodone Oral Solution",
"description": "The Supply of Oxycodone Oral Solution to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement. It is envisaged a maximum of 6 Suppliers will be awarded.",
"status": "complete",
"value": {
"amount": 175919,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "18",
"title": "Lot 18 - All Other Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines",
"description": "Supply of all other Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine in a range of presentations. The Authority intends awarding each line within this Lot to a single supplier.",
"status": "complete",
"value": {
"amount": 22987719,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
},
{
"id": "3",
"title": "Lot 3 Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection",
"description": "The Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single supplier.",
"status": "complete",
"value": {
"amount": 1136874,
"currency": "GBP"
},
"hasOptions": false,
"submissionTerms": {
"variantPolicy": "notAllowed",
"electronicCataloguePolicy": "required"
},
"contractPeriod": {
"durationInDays": 720
},
"hasRenewal": true,
"renewal": {
"description": "Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
}
}
],
"lotDetails": {
"maximumLotsBidPerSupplier": 2147483647
},
"bidOpening": {
"date": "2017-10-03T17:00:00Z"
},
"contractTerms": {
"hasElectronicPayment": true,
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed"
},
"coveredBy": [
"GPA"
],
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015"
},
{
"type": "technical",
"description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. (d) Potential Framework Participants must be able to demonstrate the existence of a valid and current CE declaration of conformity for all tendered Medical Devices at the date of submission of the tender.",
"minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under Technical and Professional ability: Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products. (d) Confirmation of existence of a valid and current CE declaration of conformity at the date of the tender submission should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control"
}
]
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"techniques": {
"hasFrameworkAgreement": true
},
"classification": {
"id": "33600000",
"scheme": "CPV"
},
"reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"hasRecurrence": false
},
"language": "EN",
"description": "The estimated values referred to in Section II.I.5 and all Lots cover the twently-four (24) months contract duration and the twenty-four (24) month extension period of the framework agreement. (SC Ref:529550)",
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000510037"
},
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000510037"
}
],
"noticetype": "OJEU - F3 - Contract Award Notice",
"awards": [
{
"id": "NP40917-1",
"title": "Lot 2 Oxycodone Injections",
"relatedLots": [
"2"
]
},
{
"id": "NP40917-2",
"title": "Lot 3 Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection",
"relatedLots": [
"3"
]
},
{
"id": "NP40917-3",
"title": "Lot 6 Fentanyl Tablets (Sublingual)",
"relatedLots": [
"6"
]
},
{
"id": "NP40917-4",
"title": "Lot 7 Fentanyl Sf Tablet (Buccal)",
"relatedLots": [
"7"
]
},
{
"id": "NP40917-5",
"title": "Lot 8 - Fentanyl Transdermal Patch",
"relatedLots": [
"8"
]
},
{
"id": "NP40917-6",
"title": "Lot 10 - Lidocaine Chlorhexidine Gel",
"relatedLots": [
"10"
]
},
{
"id": "NP40917-7",
"title": "Lot 9 - Hydromorphone Capsule",
"relatedLots": [
"9"
]
},
{
"id": "NP40917-8",
"title": "Lot 11 - Morphine Sulfate Modified-Release capsule (12Hr)",
"relatedLots": [
"11"
]
},
{
"id": "NP40917-9",
"title": "Lot 12 - Morphine Sulfate Modified-Release capsule (24Hr)",
"relatedLots": [
"12"
]
},
{
"id": "NP40917-10",
"title": "Lot 13 - Morphine Sulfate Modified-Release Tablet",
"relatedLots": [
"13"
]
},
{
"id": "NP40917-11",
"title": "Lot 14 - Oxycodone Hydrochloride Capsule",
"relatedLots": [
"14"
]
},
{
"id": "NP40917-12",
"title": "Lot 15 - Propofol Injection",
"relatedLots": [
"15"
]
},
{
"id": "NP40917-13",
"title": "Lot 16 - Tramadol Hydrochloride Modified Release Tablet",
"relatedLots": [
"16"
]
},
{
"id": "NP40917-14",
"title": "Lot 17 - Oxycodone Oral Solution",
"relatedLots": [
"17"
]
},
{
"id": "NP40917-15",
"title": "Lot 1 Baclofen Intrathecal Injections",
"relatedLots": [
"1"
]
},
{
"id": "NP40917-16",
"title": "Lot 4 Oxycodone Hydrochloride Prolonged Release Tablets",
"relatedLots": [
"4"
]
},
{
"id": "NP40917-17",
"title": "Lot 5 Buprenorphine Patches",
"relatedLots": [
"5"
]
},
{
"id": "NP40917-18",
"title": "Lot 18 - All Other Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines",
"relatedLots": [
"18"
]
}
],
"contracts": [
{
"id": "NP40917-1",
"awardID": "NP40917-1",
"title": "Lot 2 Oxycodone Injections",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-2",
"awardID": "NP40917-2",
"title": "Lot 3 Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-3",
"awardID": "NP40917-3",
"title": "Lot 6 Fentanyl Tablets (Sublingual)",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-4",
"awardID": "NP40917-4",
"title": "Lot 7 Fentanyl Sf Tablet (Buccal)",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-5",
"awardID": "NP40917-5",
"title": "Lot 8 - Fentanyl Transdermal Patch",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-6",
"awardID": "NP40917-6",
"title": "Lot 10 - Lidocaine Chlorhexidine Gel",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-7",
"awardID": "NP40917-7",
"title": "Lot 9 - Hydromorphone Capsule",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-8",
"awardID": "NP40917-8",
"title": "Lot 11 - Morphine Sulfate Modified-Release capsule (12Hr)",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-9",
"awardID": "NP40917-9",
"title": "Lot 12 - Morphine Sulfate Modified-Release capsule (24Hr)",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-10",
"awardID": "NP40917-10",
"title": "Lot 13 - Morphine Sulfate Modified-Release Tablet",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-11",
"awardID": "NP40917-11",
"title": "Lot 14 - Oxycodone Hydrochloride Capsule",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-12",
"awardID": "NP40917-12",
"title": "Lot 15 - Propofol Injection",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-13",
"awardID": "NP40917-13",
"title": "Lot 16 - Tramadol Hydrochloride Modified Release Tablet",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-14",
"awardID": "NP40917-14",
"title": "Lot 17 - Oxycodone Oral Solution",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-15",
"awardID": "NP40917-15",
"title": "Lot 1 Baclofen Intrathecal Injections",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-16",
"awardID": "NP40917-16",
"title": "Lot 4 Oxycodone Hydrochloride Prolonged Release Tablets",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-17",
"awardID": "NP40917-17",
"title": "Lot 5 Buprenorphine Patches",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
},
{
"id": "NP40917-18",
"awardID": "NP40917-18",
"title": "Lot 18 - All Other Analgesics & Anaesthetics, Musculoskeletal & Joint Disease Generic Medicines",
"status": "active",
"dateSigned": "2017-12-22T00:00:00Z"
}
],
"relatedProcesses": [
{
"id": "1",
"relationship": [
"planning"
],
"scheme": "EU-OJ",
"identifier": "2017/S 169-346685"
}
]
}